Determinants of psoriatic arthritis in patients with psoriasis

References

• Moll J, Wright V. Psoriatic arthritis. Semin. Arthritis. Rheum.3, 55–78 (1973).
   PubMedGoogle Scholar
• Mease PJ, Goffe BS. Diagnosis and treatment of psoriatic arthritis. J. Am. Acad. Dermatol.52, 1–19 (2005).
   PubMed Web of Science ®Google Scholar
• Gladman DD. Psoriatic arthritis. In: Kelly’s Textbook of Rheumatology. 7th Edition. Harris ED, Budd RC, Firestein GS et al. (Eds). WB Saunders Co., PA, USA, 1155–1164 (2004).
   Google Scholar
• Mease PJ. Psoriatic arthritis update. Bull. NYU Hosp. J. Dis.64, 25–31 (2006).
   PubMedGoogle Scholar
• Cats A. Psoriasis and arthritis. Cutis.46, 323–329 (1990).
   PubMed Web of Science ®Google Scholar
• Gladman DD. Psoriatic arthritis. Dermatol. Ther.22, 40–55 (2009).
   PubMed Web of Science ®Google Scholar
• O’Neill T, Silman AJ. Psoriatic arthritis. Historical background and epidemiology. Baillieres. Clin. Rheumatol.8, 245–261 (1994).
   PubMed Web of Science ®Google Scholar
• Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J. Rheumatol.27, 1247–1250 (2000).
   PubMed Web of Science ®Google Scholar
• Bruce IN. Psoriatic arthritis: clinical features. In: Rheumatology. 3rd Edition. Hochberg MC, Silman JS, Smolen ME, Weinblatt M, Weisman M (Eds). Mosby, PA, USA, 1241–1252 (2003).
   Google Scholar
• Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am. J. Clin. Dermatol.4, 441–447 (2003).
   PubMed Web of Science ®Google Scholar
• Savolainen E, Kaipianen-Seppanen O, Kroger L, Luosujarvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: result from the Kuopio 2000 arthritis survey. J. Rheumatol.30, 2460–2468 (2003).
   PubMed Web of Science ®Google Scholar
• Soderlin MK; Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann. Rheum. Dis.61, 911–915 (2002).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J. Rheumatol.22, 675–679 (1995).
   PubMed Web of Science ®Google Scholar
• Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann. Rheum. Dis.62, 68–70 (2003).
   PubMed Web of Science ®Google Scholar
• Pitzalis C. Skin and joint disease in psoriatic arthritis: what is the link?. Br. J. Rheumatol.37, 480–483 (1998).
   PubMedGoogle Scholar
• Taylor WJ, Zmierczak HG; Helliwell PS. Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J. Rheumatol.32, 974–977 (2005).
   PubMed Web of Science ®Google Scholar
• Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br. J. Rheumatol.3, 339–345 (1991).
   Google Scholar
• Scarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease?. J. Rheumatol.33, 210–212 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis. Rheum.54, 2665–2673 (2006).
   PubMed Web of Science ®Google Scholar
• Barton AC, Bruce IN, Silman AJ. Genetic studies of psoriatic arthritis: dissecting joints and skin. J. Rheumatol.28, 3–5 (2001).
   PubMedGoogle Scholar
• Eastmond CJ. Psoriatic arthritis. Genetics and HLA antigens. Baillieres. Clin. Rheumatol.8, 263–276 (2004).
   Google Scholar
• Moll JM, Wright V. Familial occurrence of PsA. Ann. Rheum. Dis.32, 181–201 (1973).
   PubMed Web of Science ®Google Scholar
• Myers A, Kay LJ, Lynch SA, Walker DJ. Recurrence risk for psoriasis and psoriatic arthritis within sibships. Rheumatology44, 773–776 (2005).
   PubMed Web of Science ®Google Scholar
• Rahman P, Gladman DD, Schentag C, Petronis A. Excessive paternal transmission in psoriatic arthritis. Arthritis. Rheum.42, 1228–1231 (1999).
   PubMed Web of Science ®Google Scholar
• Swanbeck G, Inerot A, Martinsson T et al. Genetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands. Br. J. Dermatol.137, 939–942 (1997).
   PubMed Web of Science ®Google Scholar
• Rahman P, Gladman DD, Khraishi M et al. Influence of parental history on the recurrence risk of siblings with psoriatic arthritis (abstract). J. Rheumatol.30, 1885 (2003).
   Google Scholar
• Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann. Rheum. Dis.64(Suppl. II), ii37–ii39 (2005).
   PubMedGoogle Scholar
• Callis Duffin K, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. J. Rheumatol.35, 1449–1453 (2008).
   PubMed Web of Science ®Google Scholar
• Gudjonsson JE, Karason A, Antonsdottir AA et al. HLA-Cw6 positive and HLA-Cw6 negative patients with psoriasis vulgaris have distinct clinical features. J. Invest. Dermatol.118, 362–365 (2002).
   PubMed Web of Science ®Google Scholar
• Martinez-Borra J, Gonzalez S, Santos-Juanes J et al. Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology42, 1089–1092 (2003).
   PubMed Web of Science ®Google Scholar
• Queiro R, Torre JC, Gonzalez S, Lopez-Larrea C, Tinture T, Lopez-Lagunas I. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. J. Rheumatol.30, 505–507 (2003).
   PubMed Web of Science ®Google Scholar
• Queiro R, Gonzalez S, Lopez-Larrea C et al.HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res. Ther.8, R185 (2006).
   Google Scholar
• Gonzalez S, Martinez-Borra J, Lopez-Vazquez A, Garcia-Fernandez S, Torre-Alonso JC, Lopez-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J. Rheumatol.29, 973–978 (2002).
   PubMed Web of Science ®Google Scholar
• Rahman P, Siannis F, Butt C et al. TNF α polymorphisms and risk of psoriatic arthritis. Ann. Rheum. Dis.65, 919–923 (2006).
   PubMed Web of Science ®Google Scholar
• Korendowych E, Dixey J, Cox B, Jones S, McHugh N. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J. Rheumatol.30, 96–101 (2003).
   PubMed Web of Science ®Google Scholar
• Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis. Scand. J. Rheumatol.33, 318–322 (2004).
   PubMed Web of Science ®Google Scholar
• Karason A, Gudjonsson JE, Upmanyu R et al. A susceptibility gene for psoriatic arthritis maps to chromosome 16p: evidence for imprinting. Am. J. Hum. Genet.72, 125–131 (2003).
   PubMed Web of Science ®Google Scholar
• Liu Y, Helms C, Liao W et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PloS. Genet.28, 4, e1000041 (2008).
   Google Scholar
• Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet.80273–290 (2007).
   PubMed Web of Science ®Google Scholar
• Tsunemi Y, Saeki H, Nakamura K et al. Interleukin-12 p40 gene (IL12B) 3’-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci.30, 161–166 (2002).
   PubMed Web of Science ®Google Scholar
• Consortium tWTCC. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature447, 661–683 (2007).
   PubMed Web of Science ®Google Scholar
• Batliwalla FM, Baechler EC, Xiao X et al. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immunol.6, 388–397 (2005).
   PubMed Web of Science ®Google Scholar
• Batliwalla FM, Li W, Ritchlin CT et al. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol. Med.11, 21–29 (2005).
   PubMed Web of Science ®Google Scholar
• Barker JNWN. The immunopathology of psoriasis. Baillieres. Clin. Rheumatol.8, 429–438 (1994).
   PubMedGoogle Scholar
• Veale D, Ritchlin C, Fitzgerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann. Rheum. Dis.65(Suppl. II), ii26–ii29 (2005).
   Google Scholar
• Richtlin C. Psoriatic disease – from skin to bone. Nat. Clin. Pract. Rheumatol.3, 698–706 (2007).
   PubMedGoogle Scholar
• Veale DJ, Barnes L, Rogers S, Fitzgerald O. Immunohistochemical markers for arthritis in psoriasis. Ann. Rheum. Dis.53, 450–454 (1994).
   PubMed Web of Science ®Google Scholar
• Neumüller J, Dunky A, Burtscher H, Jilch R, Menzel JE. Interaction of monocytes from patients with psoriatic arthritis with cultured microvascular endothelial cells. Clin. Immunol.98, 143–152 (2001).
   PubMed Web of Science ®Google Scholar
• van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann. Rheum. Dis.65, 1551–1557 (2006).
   PubMed Web of Science ®Google Scholar
• Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J. Rheumatol.25, 1544–1552 (1998).
   PubMed Web of Science ®Google Scholar
• Costello P, Bresnihan B, O’Farrelly C, Fitzgerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. J. Rheumatol.26, 1117–1124 (1999).
   PubMed Web of Science ®Google Scholar
• Panayi G. Immunology of psoriasis and psoriatic arthritis. Baillieres. Clin. Rheumatol.8, 419–427 (1994).
   PubMedGoogle Scholar
• Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest.111, 821–831 (2003).
   PubMed Web of Science ®Google Scholar
• Szodoray P, Alex P, Chappell-Woodward CM et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology46, 417–425 (2007).
   PubMed Web of Science ®Google Scholar
• Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol.180, 7423–7430 (2008).
   PubMed Web of Science ®Google Scholar
• Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflamatory protein-3 α/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol.164, 6621–6632 (2000).
   PubMed Web of Science ®Google Scholar
• Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol.8, 369–377 (2007).
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med.203, 2673–2679 (2006).
   PubMed Web of Science ®Google Scholar
• Myers A, Lakey R, Cawston TE, Kay LJ, Walker DJ. Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings. Rheumatology.42, 272–276 (2003).
   Google Scholar
• Ritchlin CT, Proulx S, Schwarz ES. Translational perspectives on psoriatic arthritis. J. Rheumatol.36(Suppl.), 30–34 (2009).
   Web of Science ®Google Scholar
• Kruithof E, Baeten D, De Rycke L et al. Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res. Ther.7, R569–R580 (2005).
   PubMed Web of Science ®Google Scholar
• Turkiewicz AM. Moreland LW. Psoriatic arthritis. Current concepts on pathogenesis-oriented therapeutic options. Arthritis. Rheum.56, 1051–1066 (2007).
   PubMedGoogle Scholar
• Fearon U, Griosios K, Fraser A et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J. Rheumatol.30, 260–268 (2003).
   PubMed Web of Science ®Google Scholar
• Krueger J, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann. Rheum. Dis.64(Suppl. 2), ii30–ii36 (2005).
   PubMed Web of Science ®Google Scholar
• Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin. Dermatol.25, 606–615 (2007).
   PubMed Web of Science ®Google Scholar
• Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J. Rheumatol.27, 1699–1702 (2000).
   PubMed Web of Science ®Google Scholar
• Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann. Rheum. Dis.67, 672–676 (2008).
   PubMed Web of Science ®Google Scholar
• Martin MP, Nelson G, Lee JH et al. Susceptibility to psoriatic arthritis: influence of activating Killer Immunoglobulin-like Receptor genes in the absence of their corresponding HLA ligands. J. Immunol.169, 2818–2822 (2002).
   PubMed Web of Science ®Google Scholar
• Olivieri I, Padula A, D’Angelo S, Scarpa R. Role of trauma in psoriatic arthritis. J. Rheumatol.35, 2085–2087 (2008).
   PubMed Web of Science ®Google Scholar
• Buckley WR, Raleigh RL. Psoriasis with acro-osteolysis. N. Engl. J. Med.261, 539–541 (1959).
   PubMed Web of Science ®Google Scholar
• Langevitz P, Buskila D, Gladman DD. Psoriatic arthritis precipitated by physical trauma. J. Rheumatol.17, 695–697 (1990).
   PubMed Web of Science ®Google Scholar
• Sandorfi N, Freundlich B. Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. J. Rheumatol.24, 187–192 (1997).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am. J. Pathol.172, 961–971 (2008).
   PubMed Web of Science ®Google Scholar
• McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of ‘synovial-entheseal complex’ and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis. Rheum.56, 2482–2491 (2007).
   PubMed Web of Science ®Google Scholar
• Gisondi P, Tinazzi I, El-Dalati G et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study. Ann. Rheum. Dis.67, 26–30 (2008).
   PubMed Web of Science ®Google Scholar
• Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis. Rheum.61, 233–239 (2009).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis – an analysis of 220 patients. Q. J. Med.62, 127–141 (1987).
   PubMedGoogle Scholar
• Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. J. Rheumatol.26, 1752–1756 (1999).
   PubMed Web of Science ®Google Scholar
• Eastmond CJ, Wright V. The nail distrophy of psoriatic arthritis. Ann. Rheum. Dis.38, 226–228 (1979).
   PubMed Web of Science ®Google Scholar
• McGonagle D. Tan AL, Benjamin M. The nail as a musculoskeletal appendage-implications for an improved understanding of the link between psoriasis and arthritis. Dermatology218, 97–102 (2009).
   PubMed Web of Science ®Google Scholar
• Queiro R, Ballina J, Weruaga A, Fernandez JA, Riestra JL, Torre JC. Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma. Br. J. Rheumatol.34, 1097 (1995).
   PubMedGoogle Scholar
• Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G, Moulakakis A. Extensive psoriasis induced by pegilated interferon α-2b treatment for chronic hepatitis B. Eur. J. Dermatol.15, 107–109 (2005).
   PubMed Web of Science ®Google Scholar
• Thumboo J, Uramoto K, Shbeeb MI et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J. Rheumatol.29, 757–762 (2002).
   PubMed Web of Science ®Google Scholar
• Richtlin C, Tausk F. A medical conundrum: onset of psoriasis in patients receiving anti-tumor necrosis factor agents. Ann. Rheum. Dis.65, 1541–1544 (2006).
   PubMed Web of Science ®Google Scholar
• Baeten D, Kruithof E, Van den Bosch F et al. Systematic safety follow-up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defense in the pathogenesis of the disease? Ann. Rheum. Dis.62, 829–834 (2003).
   PubMed Web of Science ®Google Scholar
• Flendrie M, Vissers WH, Creemers MC, Jong EM, Van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-α blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res. Ther.7, 666–676 (2005).
   PubMed Web of Science ®Google Scholar
• Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc. Natl Acad. Sci. USA102, 3372–3377 (2005).
   PubMed Web of Science ®Google Scholar
• Aeberli D, Seitz M, Juni P, Villiger PM. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-α inhibitors. Rheumatology44, 172–175 (2005).
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest.113, 1664–1675 (2004).
   PubMed Web of Science ®Google Scholar
• Boyle DL, Kavanaugh A. The pathobiology of psoriatic synovium. Curr. Opin. Rheumatol.20, 404–407 (2009).
   Web of Science ®Google Scholar
• Lebwohl M, Tyring SK, Hamilton TK et al. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N. Engl. J. Med.349, 2004–2013 (2003).
   PubMed Web of Science ®Google Scholar
• Viguier M, Richette P, Aubin F et al. Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis. Rheum.58, 1796–1802 (2008).
   PubMedGoogle Scholar
• Dass S, Vital EM, Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis. Rheum.56, 2715–2718 (2007).
   PubMed Web of Science ®Google Scholar
• Skov L, Baadsgaard O. Bacterial superantigens and inflammatory skin diseases. Clin. Exp. Dermatol.25, 57–61 (2000).
   PubMed Web of Science ®Google Scholar
• McNeill ME. Multiple-induced remissions of psoriatic arthritis: case report. Am. J. Obstet. Gynecol.159, 896–897 (1988).
   PubMed Web of Science ®Google Scholar
• Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J. Rheumatol.36, 361–367 (2009).
   PubMed Web of Science ®Google Scholar
• Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis when applied to patients attending a family medicine clinic. J. Rheumatol.35, 2069–2070 (2008).
   PubMed Web of Science ®Google Scholar
• Alenius GM, Stenberg B, Stenlund H, Lundblad M, Dahlqvist SR. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of psoriatic and arthritic questionnaire. J. Rheumatol.29, 2577–2582 (2002).
   PubMed Web of Science ®Google Scholar
• Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J. Am. Acad. Dermatol.57, 581–587 (2007).
   PubMed Web of Science ®Google Scholar
• Gladman DD, Schentag CT, Tom BD et al. Development and initial validation of a screening questionnaire for psoriatic arthritis; The Toronto Psoriatic Arthritis Screen (ToPAS). Ann. Rheum. Dis.68, 497–501 (2009).
   PubMed Web of Science ®Google Scholar
• Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin. Exp. Rheumatol.27, 469–474 (2009).
   PubMed Web of Science ®Google Scholar
• Zenz R, Eferl R, Kenner L et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature437, 369–375 (2005).
   PubMed Web of Science ®Google Scholar
• Curran SA, Fitzgerald OM, Costello PJ et al. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J. Immunol.172, 1935–1944 (2004).
   PubMed Web of Science ®Google Scholar
• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PloS Med.3, 1242–1248 (2006).
   Web of Science ®Google Scholar
• Queiro R, Moreno P, Sarasqueta C, Alperi M, Riestra JL, Ballina J. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit different immunogenetic profile. Clin. Exp. Rheumatol.26, 125–128 (2008).
   PubMed Web of Science ®Google Scholar
• Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology44, 1056–1060 (2005).
   PubMed Web of Science ®Google Scholar
• McGonagle D, Benjamin M, Tan AL. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr. Opin. Rheumatol.21, 340–347 (2009).
   PubMed Web of Science ®Google Scholar
• Fitzgerald O, McInnes I. Spondyloarthropathy: disease at the crossroads of immunity. Best. Pract. Res. Clin. Rheumatol.20, 949–967 (2006).
   PubMed Web of Science ®Google Scholar
• Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature449, 564–569 (2007).
   PubMed Web of Science ®Google Scholar
• Tan AL, McGonagle D. Imaging of seronegative spondyloarthritis. Best. Pract. Res. Clin. Rheumatol.22, 1045–1059 (2008).
   PubMed Web of Science ®Google Scholar
• Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease. J. Rheumatol.35, 1434–1437 (2008).
   PubMed Web of Science ®Google Scholar
• de Vlam K, Gottlieb AB, Fitzgerald O. Biological biomarkers in psoriatic disease. A review. J. Rheumatol.35, 1443–1448 (2008).
   PubMed Web of Science ®Google Scholar